BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $3.9 million, has announced a one-for-ten reverse stock split of its common stock ...

BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $3.9 million, has announced a one-for-ten reverse stock split of its common stock, ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Cuts to funding from the National Institutes of Health are sowing fear and uncertainty among local organizations and ...

BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $4.47 million, has announced a reverse stock split of its common stock shares, effective ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...